MDS Pharma ends FDA probe nightmare
MDS Pharma has decided to continue the 'consolidation' of its Canadian operations by putting an end to some activities at its Montreal facility, cutting 160 jobs.
MDS Pharma has decided to continue the 'consolidation' of its Canadian operations by putting an end to some activities at its Montreal facility, cutting 160 jobs.
German drug maker Merck KGaA is pursuing its natural products-derived drug strategy through a new deal signed with drug discovery firm AnalytiCon.
As more and more targeted drugs enter clinical trials, personalised medicine is fast becoming a reality for cancer sufferers worldwide.
The latest ethical reputations of the world's largest pharmaceutical companies have been revealed, with GlaxoSmithKline (GSK) emerging as big pharma's Mother Theresa, according to a recently-released compilation by Geneva-based ethical-monitoring...
Over 50 per cent of proteins in the body are considered too difficult to target with drugs; they are 'undruggable'. Yet it is exactly these molecules US pharma firm Avalon is focussing on.
Biopharma firm Vivalis has announced several licence agreements for its proprietary cell line technology, adding to the list of companies applying the technology to develop and commercialise new human influenza vaccines.
The fine chemicals division of Japanese contract manufacturer Daiso has taken out a license to a highly-selective technology used to synthesise chiral molecules.
CellCyte Genetics, Whatman, Nektar Therapeutics, Anesiva and Hyaluron Contract Manufacturing have all had people on the move in the world of pharmaceutical manufacturing.
Alcan Packaging Kreuzlingen is the latest company to receive certification for the new ISO standard for primary packaging, becoming the first flexible packaging firm in the world to achieve the accreditation.